Zosyn

Common Uses

Zosyn is an intravenous antibiotic used to treat moderate to severe infections caused by specific types of bacteria. It is often used in hospital settings for serious conditions.

Commonly treated infections include:

• Pneumonia: This includes community-acquired pneumonia and hospital-acquired or ventilator-associated pneumonia.
• Skin Infections: It is used for complicated skin and skin structure infections, such as cellulitis, abscesses, and diabetic foot infections.
• Intra-abdominal Infections: This includes infections like peritonitis and complicated appendicitis.
• Pelvic Inflammatory Disease: It is used to treat certain infections of the female reproductive system.

Zosyn is only intended for bacterial infections. It does not treat viral infections such as the common cold or the flu. Misusing antibiotics by taking them for viral infections can lead to antibiotic resistance, making future bacterial infections harder to treat.

How Zosyn Fights Infection

Zosyn is composed of two different medications that work together to eliminate bacterial infections in the body:

• Piperacillin is the primary antibiotic component. It belongs to the penicillin class and works by interfering with the bacteria's ability to form a stable cell wall. Without a functional cell wall, the bacteria cannot survive and eventually burst.
• Tazobactam is a beta-lactamase inhibitor. Many types of bacteria produce enzymes called beta-lactamases that can destroy antibiotics before they have a chance to work. Tazobactam blocks these enzymes, protecting the piperacillin so it can effectively kill the bacteria.

By combining these two ingredients, the medication can overcome certain bacterial defenses and treat a wide variety of serious infections. This medication is only effective against bacterial infections and will not work for viral infections such as the common cold or the flu.

Common Side Effects

While many people tolerate Zosyn well, some may experience mild side effects. Common symptoms include:

• Diarrhea or constipation
• Nausea or vomiting
• Headache
• Difficulty sleeping (insomnia)
• Rash or itching
• Pain, swelling, or redness at the injection site
• Fever

Serious Side Effects

Contact your healthcare provider immediately or seek emergency medical care if you experience any of the following serious side effects:

• Severe allergic reactions: Symptoms may include hives, swelling of the face, lips, or throat, and difficulty breathing or swallowing.
• Severe skin reactions: A red or purple skin rash that spreads and causes blistering or peeling, often accompanied by a fever or sore throat.
• Severe diarrhea: Watery or bloody diarrhea, which may be a sign of a Clostridioides difficile (C. diff) infection. This can occur during treatment or several months after the last dose.
• Seizures: The risk of seizures may be higher in individuals with kidney disease or those receiving high doses.
• Unusual bleeding or bruising: This includes nosebleeds, bleeding gums, or small red spots on the skin.
• Kidney problems: Changes in the frequency of urination or swelling in the feet and ankles.
• Low blood cell counts: Symptoms may include extreme tiredness, pale skin, or frequent infections.

This is not a complete list of all possible side effects. If you notice other symptoms, contact your healthcare provider for guidance.

Hypersensitivity Reactions

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with penicillins, including Zosyn. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity or a history of sensitivity to multiple allergens. Before starting treatment, a careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens.

Severe Cutaneous Adverse Reactions

Zosyn may cause severe cutaneous adverse reactions (SCAR), such as Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis. If a patient develops a skin rash, the medication should be discontinued and appropriate therapy initiated.

Hematologic Effects

Bleeding manifestations have occurred in some patients receiving beta-lactam antibiotics. These reactions are sometimes associated with abnormalities of coagulation tests and are more likely to occur in patients with renal failure. If bleeding manifestations occur, the antibiotic should be discontinued and appropriate therapy instituted. Additionally, leukopenia and neutropenia may occur, particularly during prolonged therapy; periodic assessment of hematopoietic function is advised.

Central Nervous System Effects

As with other penicillins, patients may experience neuromuscular excitability or seizures if higher than recommended doses are given intravenously, particularly in the presence of kidney failure.

Clostridioides difficile-Associated Diarrhea

Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of C. difficile. This can lead to diarrhea ranging in severity from mild to fatal colitis. It is important to consider this diagnosis in patients who present with diarrhea following the use of Zosyn.

Electrolyte and Renal Considerations

Zosyn contains sodium, which should be considered for patients requiring restricted salt intake. Periodic electrolyte determinations should be performed in patients with low potassium reserves, as hypokalemia may occur. Because the drug is excreted by the kidneys, the dose should be adjusted for patients with renal impairment to avoid toxicity.

Pregnancy

There are no adequate and well-controlled studies of Zosyn (piperacillin and tazobactam) in pregnant women. While animal studies have not shown evidence of harm to the fetus at doses similar to those used in humans, animal reproduction studies are not always predictive of human response. Piperacillin and tazobactam are known to cross the placenta in humans.

Because of the limited data available, Zosyn should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. If you are pregnant or planning to become pregnant, discuss the risks and benefits of this treatment with your healthcare provider.

Breastfeeding

Piperacillin is excreted in human milk in low concentrations. It is currently unknown whether tazobactam is excreted in human milk. There is also limited information regarding the effects of these drugs on a nursing infant or on milk production.

Healthcare providers generally advise caution when administering Zosyn to individuals who are breastfeeding. It is important to consult with a clinician to weigh the benefits of treatment against any potential risks to the nursing child.

Available Forms

Zosyn is available as an injection for intravenous use. It is supplied in the following formats:

• Vials: These contain a sterile powder that must be mixed with a liquid and further diluted before use.
• Pharmacy bulk vials: These contain a sterile powder intended for use in a pharmacy to prepare doses.
• Premixed containers: These are supplied as a frozen, sterile solution in plastic containers. These must be thawed before they are administered.

This medication is administered by a healthcare professional as an infusion into a vein.

FDA Approval and Indications

Zosyn, a combination of piperacillin and tazobactam, is approved by the U.S. Food and Drug Administration (FDA) for treating infections caused by susceptible bacteria. Approved indications include:

• Community-acquired and hospital-acquired (nosocomial) pneumonia
• Intra-abdominal infections
• Skin and skin structure infections
• Female pelvic inflammatory disease

Regulatory Classification

Zosyn is available only by prescription and is not a controlled substance. The FDA has approved multiple generic versions of the piperacillin and tazobactam injection, which are considered therapeutically equivalent to the brand-name product.

Safety and Monitoring

The FDA does not currently require a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) for Zosyn. Regulatory labeling includes warnings about the potential for severe allergic reactions and the risk of developing Clostridioides difficile-associated diarrhea (CDAD) during or after treatment.

Factors Influencing Cost

Zosyn is an intravenous antibiotic typically administered by healthcare professionals in a hospital or clinical setting. The total cost of treatment usually includes the price of the medication, the medical supplies required for the infusion, and the fees for the healthcare staff providing the service.

Generic Availability

Generic versions of piperacillin and tazobactam are available. Generic drugs are generally less expensive than brand-name versions while providing the same therapeutic benefits. Using a generic alternative can significantly lower the cost of the medication.

Insurance Coverage

Most health insurance plans, including Medicare and Medicaid, cover piperacillin and tazobactam when it is administered in a hospital or outpatient facility. Individual out-of-pocket expenses depend on the specific terms of the insurance policy, such as deductibles, copayments, or coinsurance.

Patients should consult with their hospital's billing department or their insurance provider to get a detailed estimate of the costs associated with their specific treatment plan.